logo
Horrified locals speak out after latest 'heartbreaking' scenes on Aussie beaches

Horrified locals speak out after latest 'heartbreaking' scenes on Aussie beaches

Yahoo2 days ago
Devastated locals are once again sharing their concerns after thousands of dead sea creatures — the latest victims of Australia's worst algal bloom — littered their beaches on Wednesday.
The mass kill left South Australian residents shaking their heads as they wandered along the shoreline stretching from Seacliff to Brighton, south of Adelaide, this week, dodging decaying fish, abalone, crabs, octopus and even a black swan.
'It's absolutely heartbreaking, especially in an area where we're trying to raise our children and to bring them to our local beach, and to see this is absolutely heartbreaking and we've got to do something about it,' local mum Amelia Crago told 7News after visiting the area.
More than 14,000 observations of dead marine animals have been recorded since the massive, toxic algal bloom first began to spread in March, impacting 450 species, but fisherman Roger Hopkins told the program the devastation this week was 'the worst' he had witnessed yet.
Australian Greens Senator Sarah Hanson-Young, who has called for the Albanese government to declare the situation a 'national disaster' said Seacliff was just one of the many beaches that have 'become a marine graveyard' as the algae continues to destroy everything in its path across the coastline.
View this post on Instagram
A post shared by Sarah Hanson-Young (@sarah_hansonyoung)
Lifesaver hospitalised for three days after falling ill
It's also taking its toll on beachgoers, with Port Elliot lifesaver Rachel Kennedy revealing to The Advertiser this week that her asthmatic daughter recently ended up in the hospital with respiratory issues due to the algal bloom. She said her two daughters were on patrol when they both began to feel the effects, prompting them to close the beach and warn others not to enter the water.
'One of my daughters, who is asthmatic but had never been in hospital, ended up in hospital for three days… that was quite scary,' she told the publication.
South Australia's Department of Environment and Water (DEW) previously told Yahoo News it is keeping a close eye on the situation and carrying out daily testing of state waters, but there is not much the authorities can do to stop or reduce the impact of the algal bloom.
Warning 'nowhere is safe' as Australia's 500km toxic problem spreads
Calls for national response as Aussie beaches turn into 'graveyards of fish'
Ominous blood-like substance off Aussie coast after 9,000 animals die
Premier vows to build 15 hectares of new reef along SA coastline
However, following the outrage from locals this week, Premier Peter Malinauskas told 7News he's committing to building 15 hectares of new reef in 15 different locations along the state's coastline to help prevent future blooms.
The Malinauskas state government has connected the bloom to climate change and voiced concerns the problem will occur again. It is understood to have spoken to the Commonwealth about updating the 2018 Disaster Recovery Funding Arrangements, so future blooms can be declared natural disasters like floods or bushfires, streamlining the process for securing federal funding.
Late last month, it was announced the Albanese government had committed $14 million to help the state respond to the problem. The money is likely to be used to pay for the clean-up of dead marine life from SA's beaches, support impacted businesses, bolster community awareness about the bloom and invest in science and research to better understand the incident.
While Environment Minister Murray Watt has described the bloom and its impacts as 'incredibly disturbing', he said he's not able to officially declare the situation a natural disaster.
'There's no doubting whatsoever that this is a very serious environmental event facing South Australia,' Mr Watt said. 'We are in uncharted waters here.'
Dr Scott Bennett, from the University of Tasmania Institute of Marine and Antarctic Studies, previously told Yahoo News that a theory has emerged that the bloom is now 'fuelling itself'. 'The dead stuff is just decomposing, and all those nutrients are then recycling back into the system,' he said.
with AAP
Do you have a story tip? Email: newsroomau@yahoonews.com.
You can also follow us on Facebook, Instagram, TikTok, Twitter and YouTube.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cannabis, Psychedelics Get High Marks for Eating Disorder
Cannabis, Psychedelics Get High Marks for Eating Disorder

Medscape

timean hour ago

  • Medscape

Cannabis, Psychedelics Get High Marks for Eating Disorder

TOPLINE: Cannabis and psychedelics were rated as the most effective drugs for symptom relief by survey participants with eating disorders (EDs), including anorexia nervosa, bulimia nervosa, and binge eating disorder (BED). On the other hand, patients perceived prescription antidepressants as mainly providing benefits for overall mental health. METHODOLOGY: Researchers analyzed responses to the international online MED-FED survey between 2022 and 2023. The study included more than 6000 adults (mean age, 24.3 years; 94% women; 82% White) who self-reported an ED (62%) or disordered eating (38%) and were predominantly from Australia (30%), the UK (21%), and the US (18%). The highest percentage of ED type was anorexia nervosa (41%), bulimia nervosa (19%), and BED (11%). Additionally, 65% had comorbid depression. The survey included questions on recent (previous 12 months) use of prescription drugs, caffeine, alcohol, tobacco and nicotine, cannabis, psychedelics, prosocial or party drugs such as 3,4-methylenedioxymethamphetamine and gamma-hydroxybutyric acid, stimulants, and opioids. Participants rated their agreement on a 5-point Likert scale regarding each drug's effects on ED symptoms, overall benefits for mental health, and unpleasant side effects. TAKEAWAY: Cannabis was used by 56% of participants, with its daily use being particularly high among those with avoidant/restrictive food intake disorder (odds ratio, 2.4; P < .001). Psilocybin and cannabis received the highest positive rating for relieving ED symptoms (mean rating, 0.50 for both), followed by lysergic acid diethylamide (mean rating, 0.3). Prescription antidepressants were rated effective for improving overall mental health but not for relieving ED symptoms, with the exceptions of lisdexamfetamine for BED (mean rating, 1.14) and fluoxetine for bulimia nervosa (mean rating, 0.50). Alcohol and amphetamines (mean rating, -0.52 for both) received the poorest ratings for symptom improvement. Unpleasant adverse effects were least likely to be reported with the use of lamotrigine (mean rating, -0.49), illicitly sourced diazepam (mean rating, -0.40), bupropion (mean rating, -0.29), and psilocybin (mean rating, -0.30). IN PRACTICE: 'These findings highlight an important pattern: with traditional medications often falling short in treating eating disorders directly, while many individuals are self-medicating with substances they perceive as helpful,' lead investigator Sarah-Catherine Rodan, the University of Sydney, Sydney, Australia, said in a press release. The results also suggest that 'more research, including large clinical trials, should be undertaken around the beneficial effects of cannabis and psychedelics for people with eating disorders,' she added. SOURCE: The study was published online on July 22 in JAMA Network Open. LIMITATIONS: The study predominantly involved high-income English-speaking countries and participants with internet access, potentially introducing a selection bias. The sample may have also been influenced by novelty-seeking individuals or those with positive experiences with drugs. The reliance on self-diagnosis without formal assessment of EDs or comorbid conditions, along with potential recall bias in self-reporting of drug use and clinical features, limited the generalizability of findings. Some findings involved relatively small numbers of people with specific diagnoses using specific drugs, and the positive public perception of cannabis and psychedelics may have influenced ratings through expectation and placebo effects. DISCLOSURES: The study was funded by the Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney. Several investigators reported having financial ties with various sources, and some reported holding share options, patents, and expert-witness roles with pharmaceutical and cannabis-industry entities. Full details are listed in the original article. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

CLL: More Protection, More Problems?
CLL: More Protection, More Problems?

Medscape

time5 hours ago

  • Medscape

CLL: More Protection, More Problems?

TOPLINE: In a 14-year study of 6217 patients with chronic lymphocytic leukemia (CLL), regular immunoglobulin replacement therapy (IgRT) was associated with higher infection rates during treatment periods than during nontreatment periods. Monthly infection-related hospitalizations doubled, while IgRT use quadrupled over the study period. METHODOLOGY: Researchers conducted a retrospective longitudinal analysis of 6217 patients diagnosed with CLL between 2008 and 2022 in Victoria, Australia, using linked hospital and death data. Analysis included Kaplan-Meier survival analyses to estimate survival, infection incidence, and IgRT use, while Cox survival analyses explored associations between infections and IgRT in regular prophylactic users. Investigators tracked 753 patients (12.1%) who received IgRT, with 524 (8.4%) receiving regular treatment, defined as at least three IgRT sessions within a 5-month period, with no gaps longer than 3 months. TAKEAWAY: Patients experiencing serious infections showed significantly higher mortality rates (0.090; 95% CI, 0.074-0.110) than those without infections (0.008; 95% CI, 0.007-0.009). Regular IgRT users demonstrated higher infection incidence during treatment periods (0.056; 95% CI, 0.052-0.060) vs nontreatment periods (0.038; 95% CI, 0.035-0.042). Serious infections were strongly associated with IgRT initiation (hazard ratio [HR], 31.91; 95% CI, 24.94-40.82) and cessation (HR, 3.81; 95% CI, 2.71-5.35). The median survival time from CLL diagnosis was 10 years, with infection-related hospitalizations doubling, while IgRT use quadrupled over the 14-year follow-up period. IN PRACTICE: 'Given the increasing use and costs of IgRT, these results highlight the need to evaluate the causal association between IgRT and infections and determine which patient subgroup, and at what point during their disease course, may benefit the most from IgRT treatment. Further research, particularly randomized controlled trials, is needed to fully understand the effectiveness and cost-effectiveness of IgRT in this patient population,' wrote the authors of the study. SOURCE: The study was led by Sara Carrillo de Albornoz, School of Public Health and Preventive Medicine, Monash University in Melbourne, Australia. It was published online in Blood Advances. LIMITATIONS: According to the authors, the retrospective design and potential selection bias were significant limitations. The study lacked key clinical prognostic factors, disease severity data, and cancer treatment-related information. Additionally, researchers could not stratify patients or adjust for infection risk, particularly underlying hypogammaglobulinemia. The analysis was limited to serious infections, while outpatient infections and oral antibiotic treatments outside of hospital were not captured. DISCLOSURES: The study was funded by the Medical Research Future Fund Value-Ig Study. Erica Wood and Zoe McQuilten disclosed receiving grant funding from CSL Behring unrelated to this study and research funding to their institution from Abbvie, Amgen, AstraZeneca, Beigene, Celgene, Janssen, New Zealand Blood Service, Novartis, Sanofi, and Takeda. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Teamwork Boosts Primary Care Job Satisfaction, Cuts Stress
Teamwork Boosts Primary Care Job Satisfaction, Cuts Stress

Medscape

time7 hours ago

  • Medscape

Teamwork Boosts Primary Care Job Satisfaction, Cuts Stress

TOPLINE: Primary care physicians who worked as part of a multidisciplinary team were more likely to have higher job satisfaction and lower occupational stress levels. METHODOLOGY: Researchers conducted a secondary analysis of survey data from 2019 of primary care physicians carried out across 11 western countries to explore the relationship between team composition in primary care and occupational well-being. More than 13,000 physicians from Australia, Canada, Germany, France, the Netherlands, New Zealand, Sweden, Norway, Switzerland, the UK, and the US were included. Occupational stress was measured on a scale from 'extremely stressful' to 'not at all stressful.' Job satisfaction was assessed using a similar scale. The composition of primary care staff could have included nurses, nurse practitioners, physicians or medical assistants, nutritionists, pharmacists, mental health professionals, physical therapists, and social workers. Five clusters (traditional, multidisciplinary, nurse-centered, psychologist-centered, and physiotherapist-centered models) were identified. TAKEAWAY: Almost half of physicians reported high levels of occupational stress, with a similar proportion experiencing job satisfaction. Job satisfaction was notably higher among physicians when working in multidisciplinary teams (odds ratio [OR], 1.43; 95% CI, 1.26-1.62), psychologist-centered practices (OR, 1.24; 95% CI, 1.09-1.42), or nurse-centered practices (OR, 1.18; 95% CI, 1.02-1.635) than when working in traditional practices. Lower levels of occupational stress were reported for physicians working in multidisciplinary teams (OR, 0.77; 95% CI, 0.68 - 0.87) and psychologist-centered practices (OR, 0.81; 95% CI, 0.71-0.93). Occupational stress levels were higher among female physicians (OR, 1.17; 95% CI, 1.08 - 1.27), physicians aged 35 to 44 years (OR, 1.12; 95% CI, 1.01-1.25), and those with shorter consultation durations (5-10 minutes; OR, 1.76; 95% CI, 1.50-2.26). IN PRACTICE: 'The preservation of healthcare professionals' well-being is a critical issue for the sustainability of primary care systems and should not be neglected,' the authors wrote. SOURCE: The study was led by Christine Cohidon, MD, PhD, of the Department of Family Medicine at the Center for Primary Care and Public Health at the University of Lausanne in Lausanne, Switzerland. It was published online on July 4, 2025, in BJGP Open. LIMITATIONS: The classification of primary care practices might have been unclear and used random cluster naming, hence noting the composition of each cluster may be necessary for interpretation. As the outcomes were self-reported, they are subject to reporting bias. Using single-question assessments instead of validated questionnaires may have overestimated the reported frequencies of stress and satisfaction. DISCLOSURES: The analysis was funded by the University of Lausanne's Institute of Family Medicine, Switzerland. No competing interests were declared by the authors. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store